Ontario-based Linamar Corp. has formed a new medical manufacturing group, MedTech, which will focus on leveraging its expert capabilities in precision manufacturing to pursue opportunities in the medical device and precision medical component markets.

The company said MedTech will further fuel growth and diversification in line with Linamar’s 2100 strategy. The announcement builds on the medical device programs the company has launched over the past several years, including full ventilator systems and ventilator parts, part of the highly critical, expedited launch effort in response to the public health crisis created by the COVID-19 pandemic. Linamar has also successfully launched other medical device programs in automated robotic microscopy.

“Linamar has expertise and resources that are applicable beyond the markets in which it operates today as we have proven with prior diversification initiatives,” said Linda Hasenfratz, Linamar’s Executive Chair and CEO. “With a growing and aging population, the medical device and precision components market is one that is growing quickly. This is an exciting new area for Linamar to grow, and one in which we have already proven we can excel.”

By utilizing the Linamar global operating structure and manufacturing footprint, Linamar plans to manufacture precision medical components and complex medical device assemblies for the global medical market. Potential targeted products include surgical, respiratory, and imaging devices, and precision components for devices, orthopedics, and prosthesis.